T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma

Size: px
Start display at page:

Download "T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma"

Transcription

1 T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma Sylvia Hartmann Dr. Senckenberg Institute of Pathology Goethe University Frankfurt

2 Overview Borderline ALCL classical HL Borderline AITL and FTCL classical HL/NLPHL

3 Case 1 28 year-old patient enlarged cervical lymph node

4

5 CD30 PAX5

6 TIA1 ALK

7 ALK+ anaplastic large cell lymphoma, Hodgkin-like variant In PAX5-negative Hodgkin lymphoma (or cases with strong lymphohistiocytic infiltrate) -> always stain ALK!

8 Case 2 59 year-old patient Enlarged inguinal lymph node

9

10 CD30

11 CD30

12 CD30

13 PAX5

14 Granzyme B chl with cytotoxic phenotype? or ALK- ALCL?

15 Features in favor of ALK- ALCL Adult/elderly patients Morphology of hallmark cells, no eosinophilic nucleoli PAX5-negativity of tumor cells Sinusoidal expansion Stronger CD30 expression Expression of cytotoxic molecules Eosinophilia but usually less reactive lymphocytes

16 ALK- ALCL Classical Hodgkin Lymphoma

17 CD30 PAX5 ALK- ALCL Classical Hodgkin lymphoma

18 T gamma Clonality VH

19 ALK- Anaplastic large cell lymphoma In WHO revision 2016 definite entity that includes cytogenetic subsets that appear to have prognostic implications (eg, 6p25 rearrangments at IRF4/DUSP22 locus).

20 Brune et al., J Exp Med 2008 Eckerle et al., Leukemia 2009 chl ALCL

21 chl ALK- ALCL CD83 CCL22 STAT3 TUBB2B

22 Döring et al., Mod Pathol

23 Am J Surg Pathol May;36(5): CD15 CD30

24 In our patient: History of cutaneous CD30+ ALCL -> nodal relapse of primary cutaneous ALCL

25 Case 3 60 year-old female patient Generalized lymphadenopathy B symptoms, splenomegaly

26

27

28 CD30 LMP1

29 CD20 EBV-infected blastoid B cells HRS cells or HRS-like cells?

30 CD20

31 Follicular T Helper cell markers PD1 CD10

32 FDC (CD23) Angioimmunoblastic T cell lymphoma (AITL) with (clonal) EBV-infected CD30+ blasts

33 First description of EBV-infected HRS-like cells in AITL: Quintanilla-Martinez et al., Am J Surg Pathol 1999 J Pathol 2017

34 Naive B cells, mainly polyclonal

35 Diagnostic features of angioimmunoblastic T cell lymphoma (AITL) Open sinuses Expansion to perinodal tissue B cell rim along sinuses Mixed, epitheloid cell rich infiltrate Clear cells Regressive germinal centers Scattered B blasts CD30+/- and EBV+/- Expansion of FDC networks

36 CD3

37 PTCL of T FH phenotype show an aberrant CD3 -/dim CD4 + population 90% of follicular TCL 73.3% of AITL Alikhan et al., Mod Pathol 2016

38 WHO revision 2016 Nodal peripheral T-cell lymphoma with TFH phenotype which includes angioimmunoblastic T cell lymphoma Follicular T cell lymphoma

39 Case 4 54 year-old patient Single enlarged inguinal lymph node

40 chl with HRS cells or TCL with HRS-like cells??

41 Immunophenotype of HRS/HRS-like cells CD30 CD15

42 Immunophenotype of HRS/HRS-like cells CD20 PAX5 EBER

43 Immunophenotype of surrounding T cells PD1 CD10

44 Immunophenotype of surrounding T cells CXCL13 ICOS

45 Follicular T cell lymphoma (with HRS-like cells) New provisional entity in WHO revision Follicular, perifollicular or NLPHL-like pattern First described by Rüdiger et al. Am J Surg Pathol, 2000 Frequently HRS-like cells

46 Own experience of FTCL Neoplastic cells positive CD10 11/11 PD1 11/11 BCL6 11/11 ICOS 10/10 CXCL13 9/11

47 Own experience of FTCL: HRS-like cells in 11/11 cases Neoplastic T cells rosetting around HRS-like cells in 6/11 cases CD30 11/11 CD20 5/11 LMP1 7/11 CD15 2/11 PAX5 11/11 MUM1 11/11 Immunophenotype of HRS-like cells

48 HRS-like cells in 57 cases of different types of PTCL CD30 100% CD20 64% EBV 91% CD15 80% PAX5 100% Immunophenotype of HRS-like cells Nicolae et al. Am J Surg Pathol 2013

49 Delineation classical HL and T cell lymphomas with TFH phenotype chl HRS cells clonal + HRS-like cells T cell lymphomas + HRS-like cells (EBV-infected) B cells polyclonal or monoclonal T cells polyclonal T cells monoclonal Quintanilla-Martinez et al. Am J Surg Path 1999 Moroch et al., Am J Surg Path 2012 Eladl et al., Am J Surg Path 2017

50 Case 5 50-year old patient Stereotactic brain biopsy

51

52

53 CD3 CD20 PAX5 CD79

54 CD4 CD8

55 TCR gamma PCR polyclonal

56 IgH Framework I III monoclonal!

57 HHV8 MUM1 CD138 HHV8-associated plasmablastic lymphoma with aberrant CD3- expression

58 CD20 negative or only focally positive in 13/21 samples Cytoplasmic CD3 localization Other T cell antigens negative Frequent extranodal localization

59 Summary T cell lymphomas frequently contain Hodgkinlike cells Hodgkin-like cells can be part of the neoplastic clone (T cells in ALCL) or reactive bystander cells (B cells in T FH type lymphomas) Immunophenotype can be misleading

60 Kiitos! Frankfurt Martin-Leo Hansmann Claudia Döring Markus Schneider Ralf Lieberz Yvonne Michel Elena Hartung Susanne Hansen Essen Ralf Küppers Marc Weniger Anna Lollies Friederike Schwartz Tampere Martine Vornanen Bologna Stefano Pileri Claudio Agostinelli Brescia Fabio Facchetti Helsinki Marja-Liisa Karjalainen- Lindsberg Mikko Mäyränpää Oulu Saila Kauppila Outi Kuittinen Pyry Uotila

Lymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco

Lymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What s Likely to be New in the New WHO Blood 127:2375; 2016 Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What IS New in the New WHO! Patrick Treseler,

More information

Incidence. Bimodal age incidence 15-40, >55 years Childhood form (0-14) more common in developing countries M:F=1.5:1; in all subtypes except NS

Incidence. Bimodal age incidence 15-40, >55 years Childhood form (0-14) more common in developing countries M:F=1.5:1; in all subtypes except NS Hodgkin Lymphoma Hodgkin Lymphoma 30% of all lymphomas Absolute incidence unchanged Arise in lymph node, cervical region Neoplastic tissues usually contain a small number of tumor cells Incidence Bimodal

More information

Hepatic Lymphoma Diagnosis An Algorithmic Approach

Hepatic Lymphoma Diagnosis An Algorithmic Approach Hepatic Lymphoma Diagnosis An Algorithmic Approach Ryan M. Gill, M.D., Ph.D. University of California, San Francisco PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP

More information

Methods used to diagnose lymphomas

Methods used to diagnose lymphomas Institut für Pathologie Institut für Pathologie Methods used to diagnose lymphomas Prof. Dr.Med. Leticia Quintanilla-Fend Molecular techniques NGS histology Cytology AS-PCR Sanger seq. MYC Immunohistochemistry

More information

ECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas

ECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas ECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas Philippe Gaulard, Dept of Pathology, INSERM U955, Hôpital Henri Mondor, 94010 -

More information

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

88-year-old Female with Lymphadenopathy. Faizi Ali, MD 88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and

More information

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA CLASSIFICATION Lukes & Butler Rye WHO-2016 Linphocytic and/or histiocytic Nodular & diffuse Nodular Sclerosis Lymphocyte

More information

Anaplastic Large Cell Lymphoma (of T cell lineage)

Anaplastic Large Cell Lymphoma (of T cell lineage) Anaplastic Large Cell Lymphoma (of T cell lineage) Definition T-cell lymphoma comprised of large cells with abundant cytoplasm and pleomorphic, often horseshoe-shaped nuclei CD30+ Most express cytotoxic

More information

Exploring the Borderlands between Diffuse Large B-cell Lymphoma and Classical Hodgkin s Lymphoma

Exploring the Borderlands between Diffuse Large B-cell Lymphoma and Classical Hodgkin s Lymphoma Exploring the Borderlands between Diffuse Large B-cell Lymphoma and Classical Hodgkin s Lymphoma Elaine S. Jaffe National Cancer Institute Bethesda, MD, USA On the Pathological Changes In Hodgkin s Disease

More information

Immunopathology of Lymphoma

Immunopathology of Lymphoma Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.

More information

Unusual cutaneous presentation of a T-cell lymphoproliferation

Unusual cutaneous presentation of a T-cell lymphoproliferation Department of Pathology and Cytology University Hospital Centre Zagreb, Croatia Unusual cutaneous presentation of a T-cell lymphoproliferation Snjezana Dotlic, Stefan Dojcinov, Leticia Quintanilla-Fend

More information

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Megan S. Lim MD PhD University of Pennsylvania October 8, 2018 Objectives To understand how the trend toward less invasive lymph

More information

Lymphadenopathies mimicking lymphoma and vice versa. Session 3

Lymphadenopathies mimicking lymphoma and vice versa. Session 3 Lymphadenopathies mimicking lymphoma and vice versa Session T/ NK Cell System The human and rodent T and NK cell system is characterized by many highly specialized cell suopulations and functions, that

More information

Non-Hodgkin s Lymphomas Version

Non-Hodgkin s Lymphomas Version NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Non-Hodgkin s Lymphomas Version 2.2015 NCCN.org Continue Use of Immunophenotyping/ Genetic Testing in Differential Diagnosis of Mature B-Cell

More information

Peripheral T-cell Lymphomas. Current Classification and Differential Diagnosis. Elaine S Jaffe, M.D.

Peripheral T-cell Lymphomas. Current Classification and Differential Diagnosis. Elaine S Jaffe, M.D. Peripheral T-cell Lymphomas Current Classification and Differential Diagnosis Elaine S Jaffe, M.D. International T-cell Lymphoma. Study: Frequency of Subtypes Study limited to adults JCO 2008;26:4124-4130

More information

Case Report PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature

Case Report PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature Hindawi Case Reports in Hematology Volume 2017, Article ID 7531729, 4 pages https://doi.org/10.1155/2017/7531729 Case Report PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and

More information

TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma

TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma Journal of Pathology J Pathol 2017; 242: 129 133 Published online 3 May 2017 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/path.4898 BRIEF DEFINITIVE REPORT TET2 mutations in B cells of

More information

3/23/2017. Disclosure of Relevant Financial Relationships. Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?!

3/23/2017. Disclosure of Relevant Financial Relationships. Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?! Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?! Judith A. Ferry Massachusetts General Hospital Disclosure of Relevant Financial Relationships USCAP requires that all

More information

Common Problem Areas. WHO Classification. Defines separate diseases (entities) with their CLINICAL AGGRESSIVENESS LOW GRADE / HIGH GRADE

Common Problem Areas. WHO Classification. Defines separate diseases (entities) with their CLINICAL AGGRESSIVENESS LOW GRADE / HIGH GRADE WHO Classification Defines separate diseases (entities) with their CLINICAL AGGRESSIVENESS REVIEW OF MOST COMMON LYMPHOMA ENTITIES Dr Stefan Dojcinov LOW GRADE / HIGH GRADE (June 2014) The Non-Hodgkin

More information

SH/EAHP Workshop 2011 Los Angeles, California, USA

SH/EAHP Workshop 2011 Los Angeles, California, USA SH/EAHP Workshop 2011 Los Angeles, California, USA October 27-29, 2011 Session 3 Non-Mycosis Fungoides CTCL Patty Jansen & Rein Willemze Introduction Submitted: 101 cases + 7 cases group 1: 108 Deactivated

More information

What s new on the horizon in T-cell lymphoma Elaine S Jaffe National Cancer Institute, Bethesda MD

What s new on the horizon in T-cell lymphoma Elaine S Jaffe National Cancer Institute, Bethesda MD What s new on the horizon in T-cell lymphoma Elaine S Jaffe National Cancer Institute, Bethesda MD WHO classification: where are we today? Of 12 monographs planned for 4 th Edition Bluebook series, only

More information

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing

More information

WHO UPDATE ON LYMPHOMAS. Dr Priya Mary Jacob Asst Professor, Pathology.

WHO UPDATE ON LYMPHOMAS. Dr Priya Mary Jacob Asst Professor, Pathology. WHO UPDATE ON LYMPHOMAS Dr Priya Mary Jacob Asst Professor, Pathology 3 rd 4 th 4 th revised 2001 2008 2017 The Change The Significance of the Change- Diagnostic, Prognostic The Rationale behind the change.

More information

Nodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018

Nodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018 Nodular lymphocyte predominant Hodgkin lymphoma Lymphoma Tumor Board January 5, 2018 Etiology Subtypes of Classical Hodgkin Lymphoma (chl)* Nodular sclerosing HL Most common subtype Composed of large tumor

More information

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital Immunohistochemical classification of haematolymphoid tumours Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital Malignant lymphoproliferative diseases What are they? Haematolymphoid

More information

Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders

Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders Definition A spectrum of related conditions originating from transformed or activated CD30-positive T-lymphocytes May coexist in individual

More information

Aggressive B-Cell Lymphomas

Aggressive B-Cell Lymphomas Aggressive B-cell Lymphomas Aggressive B-Cell Lymphomas Stephen Hamilton Dutoit Institute of Pathology Aarhus Kommunehospital B-lymphoblastic lymphoma Diffuse large cell lymphoma, NOS T-cell / histiocyte-rich;

More information

Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms

Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms J Hematopathol (2009) 2:65 73 DOI 10.1007/s12308-009-0034-z COMMENT Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms Megan S. Lim & Laurence de Leval & Leticia Quintanilla-Martinez

More information

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma

More information

10/31/2017. Immunodeficiencies. Outline. Discuss EBV. Non-destructive Polymorphic Monomorphic Therapies Challenges

10/31/2017. Immunodeficiencies. Outline. Discuss EBV. Non-destructive Polymorphic Monomorphic Therapies Challenges I have no financial disclosures Joo Y. Song, MD Assistant Professor of Clinical Pathology City of Hope National Medical Center Immunodeficiencies Outline Transplant Congenital Autoimmunity T-cell/immune

More information

Thomas Hodgkin and Hodgkin lymphoma

Thomas Hodgkin and Hodgkin lymphoma J Hematopathol (2014) 7:123 138 DOI 10.1007/s12308-014-0214-3 REVIEW ARTICLE Thomas Hodgkin and Hodgkin lymphoma Judith A. Ferry Received: 26 June 2014 /Accepted: 31 July 2014 /Published online: 12 August

More information

Aggressive B-cell Lymphoma 2013

Aggressive B-cell Lymphoma 2013 Aggressive B-cell Lymphoma 2013 Diffuse Large B-Cell Lymphoma Burkitt Lymphoblastic lymphoma Gray zone Intermediate DLBCL/HL Intermediate BL/DLBCL Diffuse Large B-cell lymphoma Common morphology: diffuse

More information

Update on the Classification of Aggressive B-cell Lymphomas and Hodgkin Lymphoma

Update on the Classification of Aggressive B-cell Lymphomas and Hodgkin Lymphoma Update on the Classification of Aggressive B-cell Lymphomas and Hodgkin Lymphoma Nancy Lee Harris, M. D. Massachusetts General Hospital Harvard Medical School Aggressive B-cell Lymphomas WHO 4 th Edition

More information

11/2/2017. Immunodeficiencies. Joo Y. Song, MD Assistant Professor of Clinical Pathology. I have no financial disclosures.

11/2/2017. Immunodeficiencies. Joo Y. Song, MD Assistant Professor of Clinical Pathology. I have no financial disclosures. I have no financial disclosures Joo Y. Song, MD Assistant Professor of Clinical Pathology City of Hope National Medical Center Immunodeficiencies Transplant Autoimmunity Drugs T-cell dysfunction (Age,

More information

Approach to Core Biopsy Specimens

Approach to Core Biopsy Specimens BDIAP 108th Symposium on Haematopathology Joint Meeting of the BDIAP and BLPG at-bristol, Anchor Road, Harbourside, Bristol BS1 5DB 15th - 17th May 2014 Approach to Core Biopsy Specimens Dr Stefan Dojcinov

More information

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune

More information

Many of the hematolymphoid disorders are derived

Many of the hematolymphoid disorders are derived REVIEW ARTICLE Practical Immunohistochemistry in Hematopathology: A Review of Useful Antibodies for Diagnosis Ji Lu, MD and Karen L. Chang, MD Abstract: This review article offers some useful panels of

More information

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco Types of Lymphoid Hyperplasia Follicular hyperplasia (B-cells) Paracortical

More information

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk. Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco I have nothing to disclose regarding the information to be reported in this

More information

Aggressive B-cell Lymphomas Updated WHO classification Elias Campo

Aggressive B-cell Lymphomas Updated WHO classification Elias Campo Aggressive B-cell Lymphomas Updated WHO classification Elias Campo Hospital Clinic, University of Barcelona Diffuse Large B-cell Lymphoma A Heterogeneous Category Subtypes with differing: Histology and

More information

Contents. vii. Preface... Acknowledgments... v xiii

Contents. vii. Preface... Acknowledgments... v xiii Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...

More information

Classification! Immunohistochemical classification of haematolymphoid tumours. Malignant lymphoproliferative diseases

Classification! Immunohistochemical classification of haematolymphoid tumours. Malignant lymphoproliferative diseases Immunohistochemical classification of haematolymphoid tumours Haematolymphoid Neoplasias: Leukaemia vs Lymphoma C L O N A L M A L I G N A N C I E S Stephen Hamilton-Dutoit Institute of Pathology Aarhus

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

Hodgkin Lymphomas: An Update

Hodgkin Lymphomas: An Update Hodgkin Lymphomas: An Update Roberto N. Miranda, M.D. Professor UT MD Anderson Cancer Center November 10 th, 2018 Disclosures Scientific Advisory Board, Allergan Inc, 2018 Hodgkin Lymphomas Classical Hodgkin

More information

High grade B-cell lymphomas (HGBL): Altered terminology in the 2016 WHO Classification (Update of the 4 th Edition) and practical issues Xiao-Qiu Li,

High grade B-cell lymphomas (HGBL): Altered terminology in the 2016 WHO Classification (Update of the 4 th Edition) and practical issues Xiao-Qiu Li, High grade B-cell lymphomas (HGBL): Altered terminology in the 2016 WHO Classification (Update of the 4 th Edition) and practical issues Xiao-Qiu Li, M.D., Ph.D. Fudan University Shanghai Cancer Center

More information

VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping

VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping 1 12/4/2015 9:47:24 AM 2 Hematopathology diagnostic solutions Contents VENTANA hematopathology assays 3 Detecting and subtyping

More information

Defined lymphoma entities in the current WHO classification

Defined lymphoma entities in the current WHO classification Defined lymphoma entities in the current WHO classification Luca Mazzucchelli Istituto cantonale di patologia, Locarno Bellinzona, January 29-31, 2016 Evolution of lymphoma classification Rappaport Lukes

More information

Low-grade B-cell lymphoma

Low-grade B-cell lymphoma Low-grade B-cell lymphoma Patho-Basic 11. September 2018 Stephan Dirnhofer Pathology Outline Definition LPL, MBL/CLL/SLL, MCL FL Subtypes & variants Diagnosis including Grading Transformation Summary Be

More information

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic

More information

Aggressive B-cell Lymphomas

Aggressive B-cell Lymphomas Neoplastic Hematopathology Update 2018 Aggressive B-cell Lymphomas Raju K. Pillai City of Hope National Medical Center I do not have any disclosures Disclosures Outline New entities and changes in WHO

More information

VENTANA hematopathology solutions. Deliver diagnostic confidence

VENTANA hematopathology solutions. Deliver diagnostic confidence VENTANA hematopathology solutions Deliver diagnostic confidence 2 Hematopathology diagnostic solutions Contents VENTANA hematopathology assays 3 Detecting and subtyping hematological cancers 4 The importance

More information

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour 7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic

More information

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,

More information

Robert Carswell Cancer cerebriformis of the lymphatic glands and spleen

Robert Carswell Cancer cerebriformis of the lymphatic glands and spleen Hodgkin s Lymphoma 1828 Robert Carswell Cancer cerebriformis of the lymphatic glands and spleen Hodgkin s Disease Historical Background 1832 T. Hodgkin On some morbid appearances of the absorbent glands

More information

Peripheral T-cell lymphomas

Peripheral T-cell lymphomas XXXVI REUNIÓN ANUAL Peripheral T-cell lymphomas Dr. Antonio Martinez Hospital Clinic, University ofbarcelona antonmar@clinic.ub.es Madrid, February 8th, 2013 T-NHL vs B-NHL: the T-cell paradigm lambda

More information

EQA SCHEME CIRCULATION 33 EDUCATIONAL SLIDES DR GRAEME SMITH MONKLANDS DGH

EQA SCHEME CIRCULATION 33 EDUCATIONAL SLIDES DR GRAEME SMITH MONKLANDS DGH EQA SCHEME CIRCULATION 33 EDUCATIONAL SLIDES DR GRAEME SMITH MONKLANDS DGH CASE E1 M: 68 yrs Left destructive sinonasal lesion.?lymphoma?adenocarcinoma CD20 CD10 BCL6 MIB1 Answers Diffuse large B cell

More information

NEW ENTITIES IN AGGRESSIVE B CELL LYMPHOMA. Joon Seong Park, M.D. Dept. of Hematology-Oncology Ajou University School of Medicine

NEW ENTITIES IN AGGRESSIVE B CELL LYMPHOMA. Joon Seong Park, M.D. Dept. of Hematology-Oncology Ajou University School of Medicine NEW ENTITIES IN AGGRESSIVE B CELL LYMPHOMA Joon Seong Park, M.D. Dept. of Hematology-Oncology Ajou University School of Medicine Historical background of Lymphoma classification Rappaport classification

More information

ALCL was firstly described by Stein et al. (Blood, 66:848-58) in 1985.

ALCL was firstly described by Stein et al. (Blood, 66:848-58) in 1985. ALCL was firstly described by Stein et al. (Blood, 66:848-58) in 1985. The tumour previously often misdiagnosed as malignant histiocytosis or metastatic involvement by occult carcinoma was characterised

More information

Lymph node cytopathology : A practical approach to lymphoproliferative disorders

Lymph node cytopathology : A practical approach to lymphoproliferative disorders Lymph node cytopathology : A practical approach to lymphoproliferative disorders Koray Ceyhan, M.D Department of Pathology Faculty of Medicine Ankara University Ankara, Turkey Diagnostic use of FNA in

More information

Case Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan

Case Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD Department of Pathology Jordan University Hospital Amman, Jordan The 25th Annual Congress of the ADIAP The 8/11/2013 1 5th International

More information

FOLLICULARITY in LYMPHOMA

FOLLICULARITY in LYMPHOMA FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular

More information

The 2016 updated WHO classification of lymphoid neoplasias

The 2016 updated WHO classification of lymphoid neoplasias DOI: 10.1002/hon.2399 SUPPLEMENT ARTICLE The 2016 updated WHO classification of lymphoid neoplasias Leticia Quintanilla Martinez Institute of Pathology, University Hospital Tübingen, Eberhard Karls University

More information

Methotrexate-associated Lymphoproliferative Disorders

Methotrexate-associated Lymphoproliferative Disorders Methotrexate-associated Lymphoproliferative Disorders Definition A lymphoid proliferation or lymphoma in a patient immunosuppressed with methotrexate, typically for treatment of autoimmune disease (rheumatoid

More information

Monoclonal B-cell Lymphocytosis

Monoclonal B-cell Lymphocytosis Entity Centred Approach Lymphoma Classification: WHO and Beyond Clinically meaningful categories Dr Stefan Dojcinov University Hospital of Wales, Cardiff WHO UPDATE - NEW ENTITIES Early lesions lymphoma

More information

Small B-cell (Histologically Low Grade) Lymphoma

Small B-cell (Histologically Low Grade) Lymphoma Frequency of Lymphoid Neoplasms Small B-cell (Histologically Low Grade) Lymphoma Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital B-cell neoplasms 88% Diffuse large B-cell lymphoma

More information

PTCL: morphology and pathobiology Anaplastic large cell lymphoma

PTCL: morphology and pathobiology Anaplastic large cell lymphoma PTCL: morphology and pathobiology Anaplastic large cell lymphoma Stefano A. Pileri Director Haematopathology European Institute of Oncology - Milan Alma Mater Professor of Pathology Bologna University

More information

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology

More information

DETERMINATION OF A LYMPHOID PROCESS

DETERMINATION OF A LYMPHOID PROCESS Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,

More information

Hodgkin s lymphoma: the pathologist s viewpoint

Hodgkin s lymphoma: the pathologist s viewpoint 162 REVIEW Hodgkin s lymphoma: the pathologist s viewpoint S A Pileri, S Ascani, L Leoncini, E Sabattini, P L Zinzani, P P Piccaluga, A Pileri Jr, M Giunti, B Falini, G B Bolis, H Stein... Despite its

More information

The spectrum of flow cytometry of the bone marrow

The spectrum of flow cytometry of the bone marrow The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests

More information

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative

More information

Hematopathology Specialty Conference Case #1

Hematopathology Specialty Conference Case #1 Hematopathology Specialty Conference Case #1 Robert (Bob) Ohgami, MD, PhD Assistant Professor Stanford University Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships

More information

Angioimmunoblastic T-cell lymphoma

Angioimmunoblastic T-cell lymphoma Unusual Presentation of Angioimmunoblastic T-cell Lymphoma as a Solitary Lymph Node N Ashalatha*, BN Kumarguru, BS Dayananda, AH Nagarajappa # Abstract Introduction: Angioimmunoblastic T-cell lymphoma

More information

Reac%ve and Benign Flow Cytometry findings

Reac%ve and Benign Flow Cytometry findings Reac%ve and Benign Flow Cytometry findings Lymph nodes and other /ssues Sindhu Cherian, MD University of Washington, Sea

More information

Manuel Rodriguez-Justo 1, Ayoma D Attygalle 2, Phillipa Munson 3, Giovanna Roncador 4, Teresa Marafioti 5 and Miguel A Piris 4

Manuel Rodriguez-Justo 1, Ayoma D Attygalle 2, Phillipa Munson 3, Giovanna Roncador 4, Teresa Marafioti 5 and Miguel A Piris 4 & 2009 USCAP, Inc All rights reserved 0893-3952/09 $32.00 www.modernpathology.org Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the

More information

HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING. Use of IHC. Use of Polymerase Chain Reaction (PCR) Use of Flow Cytometry

HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING. Use of IHC. Use of Polymerase Chain Reaction (PCR) Use of Flow Cytometry HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING The 2008 WHO classification system for tumors of hematopoietic and lymphoid tissues specifies that various combinations of immunophenotypic

More information

WHO 4th ED Classification of Mature B-cell Neoplasms

WHO 4th ED Classification of Mature B-cell Neoplasms WHO 4th ED Classification of Mature B-cell Neoplasms Chronic lymphocytic leukemia /Small lymphocytic lymphoma B-cell prolymphocytic leukaemia Splenic marginal zone lymphoma Hairy cell leukemia Splenic

More information

Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge

Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge J Hematopathol (2013) 6:145 150 DOI 10.1007/s12308-012-0162-8 CASE REPORT Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge Yuanming Zhang & Ihsane Ouansafi & Wayne Tam

More information

PET AND BIOMARKERS. Third international workshop on

PET AND BIOMARKERS. Third international workshop on Third international workshop on interim-pet in lymphoma PET AND BIOMARKERS Stefano A. Pileri Claudio Agostinelli Pier Paolo Piccaluga Simona Righi Lisa Argnani Pier Luigi Zinzani Andrea Gallamini Luisa

More information

Table 1: Comparison of Immunohistologic Features of NLPHL and CHL

Table 1: Comparison of Immunohistologic Features of NLPHL and CHL USCAP Hematopathology Evening Specialty Conference CASE 1: Handout Yasodha Natkunam, M.D., Ph.D. Department of Pathology Stanford University School of Medicine INTRODUCTION Nodular lymphocyte predominant

More information

9/28/2017. Follicular Lymphoma and Nodal Marginal Zone Lymphoma. Follicular Lymphoma Definition. Low-Grade B-Cell Lymphomas in WHO Classification

9/28/2017. Follicular Lymphoma and Nodal Marginal Zone Lymphoma. Follicular Lymphoma Definition. Low-Grade B-Cell Lymphomas in WHO Classification and L. Jeffrey Medeiros, MD DISCLOSURES I do not have anything to disclose Low-Grade B-Cell Lymphomas in WHO Classification Lymphoma Type Frequency Follicular lymphoma 22.1 % Extranodal MALT-lymphoma 7.6

More information

ACCME/Disclosures 4/13/2016. Clinical History

ACCME/Disclosures 4/13/2016. Clinical History ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner

More information

Diffuse large B-cell lymphoma (DLBCL) is one of the

Diffuse large B-cell lymphoma (DLBCL) is one of the Practical Applications in Immunohistochemistry Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas Dennis P. O Malley, MD; Aaron Auerbach, MD; Lawrence M. Weiss, MD Context.

More information

Recent diagnostic and therapeutic innovations of T-cell-lymphoma. Prof. Nossrat Firusian, Recklinghausen, Germany

Recent diagnostic and therapeutic innovations of T-cell-lymphoma. Prof. Nossrat Firusian, Recklinghausen, Germany Recent diagnostic and therapeutic innovations of T-cell-lymphoma Prof. Nossrat Firusian, Recklinghausen, Germany NODAL Angioimmunoblastic T-cell Lymphoma Peripheral T-cell-Lymphoma Anaplastic Large-cell-Lymphoma

More information

Original Article Sarcomatoid variant of anaplastic large cell lymphoma: a diagnostic challenge

Original Article Sarcomatoid variant of anaplastic large cell lymphoma: a diagnostic challenge Int J Clin Exp Pathol 2016;9(3):3654-3659 www.ijcep.com /ISSN:1936-2625/IJCEP0021021 Original Article Sarcomatoid variant of anaplastic large cell lymphoma: a diagnostic challenge Hong Yu 1*, Wenchao Wang

More information

Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo

Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas NAIVE -B LYMPHOCYTE MEMORY CELL CLL MCL FL MZL Small cell size Low proliferation

More information

Characteristic Histological Findings of Asymptomatic EBVassociated Lymphoproliferative Disorders in Tonsils

Characteristic Histological Findings of Asymptomatic EBVassociated Lymphoproliferative Disorders in Tonsils Journal of clinical and experimental hematopathology Vol. 58 No.3, 122-127, 2018 JC lin EH xp ematopathol Original Article Characteristic Histological Findings of Asymptomatic EBVassociated Lymphoproliferative

More information

Pathology of aggressive lymphomas

Pathology of aggressive lymphomas Institute of Pathology Pathology of aggressive lymphomas Leticia Quintanilla-Martinez Changes in the new 2016 WHO Aggressive B-cell lymphoid neoplasms Major changes that impact how cases should be evaludated

More information

Change Summary - Form 2018 (R3) 1 of 12

Change Summary - Form 2018 (R3) 1 of 12 Summary - Form 2018 (R3) 1 of 12 Form Question Number (r3) Type Description New Text Previous Text Today's date was removed 2018 N/A Today's Date Removed from Key Fields 2018 N/A HCT Type 2018 N/A Product

More information

Case Report Pitfalls in the Diagnosis of Anaplastic Large Cell Lymphoma with a Small Cell Pattern

Case Report Pitfalls in the Diagnosis of Anaplastic Large Cell Lymphoma with a Small Cell Pattern Case Reports in Hematology Volume 23, Article ID 84253, 6 pages http://dx.doi.org/.55/23/84253 Case Report Pitfalls in the Diagnosis of Anaplastic Large Cell Lymphoma with a Small Cell Pattern Rowan L.

More information

Leukaemia Section Short Communication

Leukaemia Section Short Communication Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST-CNRS Leukaemia Section Short Communication Classification of Hodgkin lymphoma over years Antonino Carbone, Annunziata

More information

Pathology of aggressive lymphomas

Pathology of aggressive lymphomas Institute of Pathology Pathology of aggressive lymphomas Leticia Quintanilla-Martinez Changes in the new 2016 WHO Aggressive B-cell lymphoid neoplasms Major changes that impact how cases should be evaludated

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/39089 holds various files of this Leiden University dissertation. Author: Cetinozman, F. Title: PD-1 Expression in primary cutaneous lymphoma Issue Date:

More information

Lymphoma and Pseudolymphoma

Lymphoma and Pseudolymphoma Lymphoma and Pseudolymphoma Laura B. Pincus, MD Co-Director, Cutaneous Lymphoma Clinic Associate Professor Dermatology and Pathology University of California, San Francisco I HAVE NO RELEVANT RELATIONSHIPS

More information

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long

More information

Aggressive B cell Lymphomas

Aggressive B cell Lymphomas Aggressive B cell Lymphomas I have nothing to disclose. Disclosures Raju K. Pillai City of Hope National Medical Center Outline WHO 2016 Classification Large B cell Lymphomas New entities and changes in

More information

Aggressive B cell Lymphomas

Aggressive B cell Lymphomas Aggressive B cell Lymphomas Raju K. Pillai City of Hope National Medical Center I have no disclosures Outline What is new in the WHO 2016 classification Insights from genomic studies Double Hit Lymphoma

More information

Pathology of the indolent B-cell lymphomas Elias Campo

Pathology of the indolent B-cell lymphomas Elias Campo Pathology of the indolent B-cell lymphomas Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas Antigen selection NAIVE -B LYMPHOCYTE MEMORY B-CELL MCL FL LPL MZL CLL Small cell

More information

Case Report Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular Dendritic Cell Sarcoma

Case Report Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular Dendritic Cell Sarcoma Hindawi Case Reports in Hematology Volume 2017, Article ID 9601094, 4 pages https://doi.org/10.1155/2017/9601094 Case Report Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular

More information

CD30 expression utilization for the accuracy of classical Hodgkin s lymphoma staging

CD30 expression utilization for the accuracy of classical Hodgkin s lymphoma staging Romanian Journal of Morphology and Embryology 2006, 47(2):113 117 ORIGINAL PAPER CD30 expression utilization for the accuracy of classical Hodgkin s lymphoma staging CORINA FLANGEA 1), ELENA POTENCZ 2),

More information